Literature DB >> 15199126

Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53.

Li Hui1, Tarek Abbas, Rafal M Pielak, Troy Joseph, Jill Bargonetti, David A Foster.   

Abstract

Phospholipase D (PLD) has been reported to generate survival signals that prevent apoptosis induced by serum withdrawal. We have now found that elevated expression of PLD also suppresses DNA damage-induced apoptosis. Since DNA damage-induced apoptosis is often mediated by p53, we examined the effect of elevated PLD expression on the regulation of p53 stabilization. We report here that PLD suppresses DNA damage-induced increases in p53 stabilization in cells where PLD has been shown to provide a survival signal. Elevated expression of PLD also led to increased expression of the p53 E3 ubiquitin ligase MDM2 and increased turnover of p53. PLD1-stimulated increases in MDM2 expression and suppression of p53 activation were blocked by inhibition of mTOR and the mitogen-activated protein kinase pathway. Although PLD did not activate the phosphatidylinositol 3-kinase (PI3K)/Akt survival pathway activate the basal levels of PI3K activity were partially required for PLD1-induced increases in MDM2. These data provide evidence that survival signals generated by PLD involve suppression of the p53 response pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15199126      PMCID: PMC480910          DOI: 10.1128/MCB.24.13.5677-5686.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

Review 1.  Phospholipase D.

Authors:  J H Exton
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

Review 2.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 3.  c-Src, receptor tyrosine kinases, and human cancer.

Authors:  J S Biscardi; D A Tice; S J Parsons
Journal:  Adv Cancer Res       Date:  1999       Impact factor: 6.242

4.  Overexpression of phospholipase D1 in human breast cancer tissues.

Authors:  D Y Noh; S J Ahn; R A Lee; I A Park; J H Kim; P G Suh; S H Ryu; K H Lee; J S Han
Journal:  Cancer Lett       Date:  2000-12-20       Impact factor: 8.679

Review 5.  Role of T antigen interactions with p53 in tumorigenesis.

Authors:  J M Pipas; A J Levine
Journal:  Semin Cancer Biol       Date:  2001-02       Impact factor: 15.707

6.  Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.

Authors:  S Ries; C Biederer; D Woods; O Shifman; S Shirasawa; T Sasazuki; M McMahon; M Oren; F McCormick
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

7.  Creation of human tumour cells with defined genetic elements.

Authors:  W C Hahn; C M Counter; A S Lundberg; R L Beijersbergen; M W Brooks; R A Weinberg
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

8.  Role for phospholipase D in receptor-mediated endocytosis.

Authors:  Y Shen; L Xu; D A Foster
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

9.  Increased activity and intranuclear expression of phospholipase D2 in human renal cancer.

Authors:  Y Zhao; H Ehara; Y Akao; M Shamoto; Y Nakagawa; Y Banno; T Deguchi; N Ohishi; K Yagi; Y Nozawa
Journal:  Biochem Biophys Res Commun       Date:  2000-11-11       Impact factor: 3.575

10.  Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor.

Authors:  A Hornia; Z Lu; T Sukezane; M Zhong; T Joseph; P Frankel; D A Foster
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

View more
  20 in total

1.  Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor.

Authors:  Robert R Lavieri; Sarah A Scott; Paige E Selvy; Kwangho Kim; Satyawan Jadhav; Ryan D Morrison; J Scott Daniels; H Alex Brown; Craig W Lindsley
Journal:  J Med Chem       Date:  2010-09-23       Impact factor: 7.446

2.  Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathway.

Authors:  Donggon Lyo; Limei Xu; David A Foster
Journal:  Biochem Biophys Res Commun       Date:  2010-05-08       Impact factor: 3.575

Review 3.  Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.

Authors:  David A Foster
Journal:  Biochim Biophys Acta       Date:  2009-03-02

Review 4.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

5.  A Repertoire of MicroRNAs Regulates Cancer Cell Starvation by Targeting Phospholipase D in a Feedback Loop That Operates Maximally in Cancer Cells.

Authors:  Kristen Fite; Lobna Elkhadragy; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2016-01-19       Impact factor: 4.272

6.  Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.

Authors:  Vanessa Rodrik; Yang Zheng; Faith Harrow; Yuhong Chen; David A Foster
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 7.  Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis.

Authors:  Wenjuan Su; Qin Chen; Michael A Frohman
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

8.  Mutation of Y179 on phospholipase D2 (PLD2) upregulates DNA synthesis in a PI3K-and Akt-dependent manner.

Authors:  Mauricio Di Fulvio; Kathleen Frondorf; Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2007-10-13       Impact factor: 4.315

9.  Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells.

Authors:  Avalon Garcia; Yang Zheng; Chen Zhao; Alfredo Toschi; Judy Fan; Natalie Shraibman; H Alex Brown; Dafna Bar-Sagi; David A Foster; Jack L Arbiser
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

10.  Soft tissue sarcoma cells are highly sensitive to AKT blockade: a role for p53-independent up-regulation of GADD45 alpha.

Authors:  Quan-Sheng Zhu; Wenhong Ren; Borys Korchin; Guy Lahat; Adam Dicker; Yiling Lu; Gordon Mills; Raphael E Pollock; Dina Lev
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.